| Pharmaceutical Excipients and Ingredients | Manufacturing and supply of micro crystalline cellulose powders and advanced pharmaceutical excipients and coatings. | Large capacity, product variety, regulatory approvals, global certifications, and strong customer relationships. | Pharmaceutical formulation companies globally (B2B). | Pharmaceutical coatings and value-added excipient grades. | 380 | 75 | Sales of excipients and coatings primarily through contracts with pharmaceutical manufacturers (B2B). | Direct sales with customized pricing based on grade and volume requirements. | Rising pharma industry demand, capacity expansions, product innovation in excipients and coatings. | Sigachi MCC, PureCoat, UltraMod |
| API Manufacturing and Sales | Active pharmaceutical ingredient production primarily for domestic market with plans for regulated markets. | Acquisition-based expertise, growing R&D capabilities, regulatory compliance focus. | Pharma companies in domestic and unregulated markets, expanding to regulated markets. | Specialty APIs with USFDA registration potential. | 80 | 15 | Sale and supply of APIs to pharma companies (B2B). | Contract sales and supply agreements. | Acquisition of Trimax Bio Sciences, increased capacity, pipeline CEP filings for U.S. market entry. | Trimax Bio Sciences API portfolio |
| Nutraceutical and Food Ingredients | Supplying ingredients for nutraceutical and food nutrition segments via dedicated subsidiary and JV operations. | Growing product portfolio, strategic global market presence through subsidiaries. | Food and nutraceutical product manufacturers. | Nutraceutical ingredient blends. | 25 | 5 | Sales contracts with food and nutrition companies (B2B). | Direct sales agreements. | Expansion into food & nutrition markets, global health trends favoring functional foods. | |
| International Subsidiaries and Joint Ventures | Regional manufacturing, distribution, and market access for pharma excipients and nutraceutical products. | Strategic location in Middle East and USA, joint ventures for market penetration. | Regional pharma and nutrition companies (B2B). | Specialized regional products and collaborations. | 20 | 5 | Sales, distribution agreements, and joint venture revenues. | Local sales with region-specific pricing strategies. | International market expansion, JV partnerships, regulatory approvals in overseas markets. | Sigachi US Inc., Sigachi MENA FZCO, Sigachi Arabia JV |
